Search Results
Jan 06, 2026, 13:27 ET Aperture Therapeutics Announces First-In-Class MMP9 Antisense Oligonucleotide Program for ALS
multiple potent MMP9-targeting ASOs capable of achieving robust knockdown of MMP9 mRNA and protein while attenuating inflammatory biomarkers implicated in ALS pathology in human iPSC-derived microglia. To enable translational pharmacology studies, the company developed a proprietary humanized MMP9 knock-in
More news about: Aperture Therapeutics
Dec 24, 2025, 08:04 ET Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval of leuprolide mesylate
in a Phase 3 clinical trial in premenopausal breast cancer in China in collaboration with its partner. Aderamastat (FP-025), a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, successfully completed a Phase 2 proof-of-concept study in allergic asthmatic patients. Future
More news about: Foresee Pharmaceuticals Co., Ltd.
Dec 12, 2025, 05:33 ET Golimumab biosimilar Gotenfia from STADA and Bio-Thera receives positive CHMP opinion
TNF-α results in reductions in C-reactive protein (CRP), Interleukin 6 (IL-6), Intercellular Adhesion Molecule 1 (ICAM-1), Matrix Metalloproteinase 3 (MMP-3), and Vascular Endothelial Growth Factor (VEGF), all inflammatory markers. The reference medicine golimumab has been approved in Europe for several
More news about: Bio-Thera Solutions, Ltd
Dec 03, 2025, 06:59 ET Aluminum Metal Powder Market worth $2.64 billion by 2030 - Exclusive Report by MarketsandMarkets™
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=104626207 Key PlayersProminent companies include Valimet, Inc. (US), MMP Industries Ltd. (India), MEPCO (India), Kymera International (US), Höganäs AB (Swden), NovaCentrix (US), Zhangqiu Metallic Pigment Co., Ltd. (China),
More news about: MarketsandMarkets
Nov 21, 2025, 11:48 ET ALKU and Mass Mentoring Partnership Award $30,000 Scholarship to Boston Student, Esmeilin Gonzalez, Celebrating the Transformative Power of Mentorship
Massachusetts.About Mass Mentoring Partnership (MMP) Founded in 1992, Mass Mentoring Partnership (MMP) is the only statewide organization dedicated to expanding quality mentoring relationships throughout Massachusetts. MMP supports more than 350 mentoring programs and youth-serving
More news about: ALKU
Nov 18, 2025, 08:00 ET Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
working closely with the FDA as we advance VS-041 through clinical development." VS-041 is an oral small molecule inhibitor of MMP-2 and -9 with a demonstrated ability to ameliorate the underlying fibroinflammation in preclinical models of HFpEF. In a Phase 1 clinical trial completed
More news about: Vasa Therapeutics
Nov 10, 2025, 09:00 ET Wellcare to Offer Medicare Advantage and Medicare Prescription Drug Plans in 205 Texas Counties in 2026
streamline services for both Medicare and Medicaid eligibles, while delivering improved outcomes. Existing Wellcare dual eligible members enrolled in our MMP or Highly Integrated Dual Eligible Special Needs Plan in the Texas counties of Dallas and Hidalgo will be automatically enrolled in their new integrated
More news about: Superior HealthPlan
Nov 07, 2025, 08:00 ET Resolution Therapeutics announces new data showcasing the potential of Regenerative Macrophage Therapy in treating cirrhosis at AASLD 2025
effect was not observed when mice were treated with non-engineered macrophages - Mouse macrophages engineered with IL-10 and MMP9 demonstrated significantly greater anti-inflammatory effect, compared to non-engineered macrophages - Distinct molecular signatures
More news about: Resolution Therapeutics
Oct 29, 2025, 06:00 ET CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS
Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS) and Medicare-Medicaid Plans (MMP) Duals.
More news about: Centene Corporation
Oct 13, 2025, 09:00 ET PDW Launches C100 Multi-Mission Payload Suite, Expanding Tactical Edge in the Field
updates. C100s can also be acquired in the MMP configuration, with payloads pre-integrated and ready to rapidly swap as required. PDW's training has been updated to provide MMP-focused interoperability and best practices. Learn more about the C100 capabilities and MMP payload suite at
More news about: PDW
Oct 09, 2025, 08:04 ET Bio-Thera Solutions Announces Expansion of Partnership with Intas Pharmaceuticals for BAT2506, a Proposed Biosimilar Referencing Simponi® (golimumab), through Exclusive Commercialization and License Agreement in Canada
TNF- results in reductions in C-reactive protein (CRP), Interleukin 6 (IL-6), Intercellular Adhesion Molecule 1 (ICAM-1), Matrix Metalloproteinase 3 (MMP-3), and Vascular Endothelial Growth Factor (VEGF), all inflammatory markers. The reference medicine golimumab has been approved in the Canada for several
More news about: Bio-Thera Solutions, Ltd
Oct 07, 2025, 03:30 ET Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025
autologous regenerative macrophage therapy with enhanced anti-fibrotic and anti-inflammatory effects. The product candidate is engineered with IL-10-MMP9 mRNA to enhance the natural regenerative properties of macrophages for superior efficacy and durability. RTX001 is being tested in the Phase I/II study
More news about: Resolution Therapeutics
Oct 02, 2025, 09:00 ET Discord Launches Newest Ad Format and Partners with AppsFlyer, Gamesight for Ads Measurement
new partnerships with AppsFlyer and Gamesight. Discord is partnering with AppsFlyer as its first mobile measurement platform (MMP) to provide advertisers with trusted, privacy-safe campaign measurement. AppsFlyer insights can be leveraged for all Video Quests on Mobile campaigns
More news about: Discord Inc.
Sep 16, 2025, 09:00 ET PDW Awarded $20 Million Army Contract for 'Transformation in Contact' Initiative
PDW received a $20.9 million award from the U.S. Army to supply C100 UAS and Multi-Mission Payloads (MMP) in support of the Army's 'Transformation in Contact' (TiC) initiative. This is the third C100 contract for the TiC initiative, part of the Army's Company
More news about: PDW
Sep 15, 2025, 07:19 ET MMP Capital to Offer More Favorable Terms Following Record-Breaking 2025 Securitization
About MMP Capital MMP Capital was founded in 2013 with a mission to be the gold standard in healthcare equipment finance in the U.S. Led by a management team with vast experience in sales, credit, and operations from several banks, leasing companies, and funding institutions, MMP Capital is
More news about: MMP Capital